Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.
暂无分享,去创建一个
William M. Lee | William M Lee | E. Schiff | K. Mounzer | K. Kardos | JayLynn Unangst | Stephen R Lee | Keith W Kardos | Eugene Schiff | Cheryl A Berne | Karam Mounzer | Alpha T Banks | Harvey A Tatum | Timothy J Friel | Michael P Demicco | Scott E Eder | Alexander Monto | Graham D Yearwood | Geraldine B Guillon | Lisa A Kurtz | Mark Fischl | Jay Lynn Unangst | Laura Kriebel | Gary Feiss | Michele Roehler | Alpha Banks | A. Monto | G. Feiss | M. Demicco | H. Tatum | S. Eder | Stephen R. Lee | C. A. Berne | T. Friel | G. Yearwood | G. Guillon | L. Kurtz | M. Fischl | Laura Kriebel | M. Roehler
[1] M. Busch,et al. Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay , 1992, Transfusion.
[2] R. Dinello,et al. Increased detection of hepatitis C virus infection in commercial plasma donors by a third‐generation screening assay , 1995, Transfusion.
[3] M. Bronner,et al. Histological and clinical outcome after liver transplantation for hepatitis C , 1997, Hepatology.
[4] F. Baralle,et al. Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users. , 1998, Journal of clinical epidemiology.
[5] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[6] R. S. Ross,et al. Performance characteristics of a transcription‐mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA , 2001, Journal of clinical laboratory analysis.
[7] C P Price,et al. Point of Care Testing , 1999, BMJ : British Medical Journal.
[8] S. Stramer,et al. Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population , 2002, Transfusion.
[9] S. Giampaoli,et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population , 2002, Gut.
[10] R. Booth,et al. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. , 2002, Addiction.
[11] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[12] L. Seeff,et al. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. , 2003, Clinical chemistry.
[13] G. Davis,et al. Projecting future complications of chronic hepatitis C in the United States , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] V. Hutse,et al. Detection of HCV antibodies in oral fluid. , 2004, Journal of virological methods.
[15] C. Pasquier,et al. Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[16] M. Ullmann,et al. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] H. Myrmel,et al. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[19] O. Grusky,et al. Outcomes of blood and oral fluid rapid HIV testing: a literature review, 2000-2006. , 2007, AIDS patient care and STDs.
[20] A. Wasley,et al. Surveillance for acute viral hepatitis--United States, 2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.
[21] A. Alzahrani. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay , 2008, Journal of medical virology.
[22] M. Symonds,et al. An evaluation of the performance of OraQuick® ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK , 2008, International journal of STD & AIDS.
[23] M. Van Ranst,et al. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[24] B. Kuehn. Silent epidemic of viral hepatitis may lead to boom in serious liver disease. , 2009, JAMA.
[25] J. McHutchison,et al. Review article: investigational agents for chronic hepatitis C , 2009, Alimentary pharmacology & therapeutics.
[26] Graham Yearwood,et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.